AMIX
SKIN

Hauser Bradley

Known title: CEO and PresidentCIK: 0001662139

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

Autonomix Gets Positive FDA Feedback, Completes Pre-Submission Meeting. The company reported that the FDA gave positive feedback that supports a 510(k) clearance pathway for its product. It also completed a pre‑submission meeting with the agency regarding its transvascular sensing platform. These steps move the regulatory process forward and may affect the company's future prospects. The stock is currently near its $7.83 support level.

this person other insiders at AMIX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

SkinHealth Systems Expands SkinStylus MicroSystem to Europe. SkinHealth Systems announced that its SkinStylus® SteriLock® MicroSystem will now be available in European markets. The move expands the company’s footprint beyond North America and could broaden its customer base. The product is a sterilization platform used in dermatology. The news comes as the stock trades near its 52‑week low, but the expansion may support future growth.

this person other insiders at SKIN

Transaction History

AMIX▲ Buy—
SKIN▲ Buy—
SKIN▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.